3 in 4 patients achieved PASI90.

31-gene expression profile identifies high-risk patients within low-risk groups.

Association seen with vildagliptin and linagliptin, but not sitagliptin.

Population-based study sheds light on a controversial association.

Biological therapies may carry benefits beyond antiarthritic effects.

Radiation is most cost-effective for local disease, and NBUVB or PUVA for generalized disease.

The Univadis App just had a makeover!

The review highlights recent advances in clinical presentation, diagnosis, management, and pathophysiology of NI

BADBIR analysis suggests an increased serious infection risk, particularly in the first year.

Some cancers are being over-researched and over-funded relative to their disease burden, new research suggests.

The utility of immunotherapy for elderly patients with melanoma is controversial.

Meta-analysis identifies relevant clinical factors.

Sauna bathing may have therapeutic potential to improve health outcomes in the general population.

Drug suitable for patients with moderate to severe disease.